GMRS NYSE Week ended 24 Jul 2026

Weekly Investor Report

GMR Solutions Inc. · Healthcare · Medical Care Facilities

Open interactive chart View report data Download investor PDF
Latest close 12.97 USD
-2.8% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is - below the Trend Line and sits at 47.4% of its 52-week range. The latest completed week returned -2.8%, after a -10.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 14d.

Setup score 29 out of 100
Latest Close 12.97 USD 24 Jul 2026
1W Return -2.8% latest completed week
4W Return -10.7% short-term follow-through
12W Return - quarterly tape
Trend Breadth 0.0% 0 of 11 weeks active
Volume Ratio 0.2x vs 13-week average
What is working
  • Next-week expectancy is positive at 60.18% based on similar historical setup states.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.8% Latest completed week; four-week move -10.7%. Indicator stack 0/50 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 60.18% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 51/100 11 relevant articles in the latest sentiment read. Event risk 14d Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is - below the Trend Line and sits at 47.4% of its 52-week range. The latest completed week returned -2.8%, after a -10.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0312-week average 0.02

12-week confirmation

Trend active0/11Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/11Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/11Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers

No recent accumulation markers. 4 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -10.7% over four weeks, - over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.8%
4W-10.7%
12W-
26W-
52W-
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change-Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength91/100Blend of value, momentum, and quality. Underlying universe rank 10; rank 1 is best.
Value96/100Relative valuation strength. Underlying universe rank 5; rank 1 is best.
Quality79/100Profitability and accounting quality. Underlying universe rank 22; rank 1 is best.
Momentum36/100Medium-term price momentum. Underlying universe rank 65; rank 1 is best.
Growth69/100Revenue and earnings growth. Underlying universe rank 32; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework91/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
3.4x
Price divided by trailing earnings.
Price / sales
0.1x
Market value relative to trailing revenue.
EV / EBITDA
5.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
15.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
38.9%
Gross profit retained from each unit of revenue.
Operating margin
12.9%
Operating profit retained from revenue.
Free-cash-flow margin
15.7%
Free cash flow generated from revenue.
Return on invested capital
9.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-4.0%
Latest one-year revenue growth.
EPS growth
144.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
74.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
4.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 11 relevant articles.

1 positive · 10 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings14dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-18.8%Distance below the 52-week high.
13-week volatility11.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher5 of 105 weeks finished lower.
Best week+13.5%Week of 29 May.
Worst week-17.7%Week of 22 May.
Latest week-2.8%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains0
Flat weeks0
Modest losses2
Sharp losses3
Recent vol11.0%13-week weekly-return volatility.
Base vol11.0%52-week weekly-return volatility.
Up/down split5/5Count of positive and negative weeks in the 52-week window.
Average skew10.1% / -9.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape29/100

Trend, activity pressure, participation, and risk combine to a 29/100 tape read.

 Indicator analysis1/100

Latest 12-week confirmation: trend 0/11, activity pressure 0/11, relative leadership 0/11.

Activity pressure 0.03; 4 reversal markers Next-Week ExpectancyPositive 60.18%

Next-week expectancy is positive with a 60.18% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors76/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 43; Small Cap Core rank 10 SVQF91/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 96.0 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 11 relevant articles.

GMR Solutions Inc. Revenue Breakdown – NYSE:GMRS Insiders50/100

No recent insider transaction evidence is stored.

 Earnings14d

Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202612.97 USD-2.8%-13.11 USD0.00-1.2MOff
17 Jul 202613.34 USD-13.8%-13.12 USD0.00-2.4MOff
10 Jul 202615.47 USD6.5%-13.10 USD0.00-3.5MOff
3 Jul 202614.52 USD-0.1%-12.80 USD0.00-4.5MOff
26 Jun 202614.53 USD9.7%-12.56 USD0.00-4.0MOff
19 Jun 202613.25 USD7.3%-12.23 USD0.00-6.1MOff
12 Jun 202612.35 USD13.3%-12.03 USD0.00-4.1MOff
5 Jun 202610.90 USD-12.8%-11.95 USD0.00-3.4MOff
29 May 202612.50 USD13.5%-12.29 USD--2.7MOff
22 May 202611.01 USD-17.7%-12.19 USD--8.2MOff
15 May 202613.37 USD--13.37 USD--15.7MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.